CE2 EFFICACY OF BRODALUMAB AND GUSELKUMAB IN PATIENTS WITH PLAQUE PSORIASIS WHO ARE INADEQUATE RESPONDERS TO USTEKINUMAB: A MATCHING ADJUSTED INDIRECT COMPARISON (MAIC)
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.050
https://www.valueinhealthjournal.com/article/S1098-3015(19)32428-3/fulltext
Title :
CE2 EFFICACY OF BRODALUMAB AND GUSELKUMAB IN PATIENTS WITH PLAQUE PSORIASIS WHO ARE INADEQUATE RESPONDERS TO USTEKINUMAB: A MATCHING ADJUSTED INDIRECT COMPARISON (MAIC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32428-3&doi=10.1016/j.jval.2019.09.050
First page :
Section Title :
Open access? :
No
Section Order :
10014